Inventor
CHATTERJEE DEB K
US41 patents
⚠️ This page may combine multiple inventors who share the name “CHATTERJEE DEB K”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LIFE TECHNOLOGIES INC
18 patentsUS5270179ADec 14, 1993
Cloning and expression of T5 DNA polymerase reduced in 3'- to-5' exonuclease activity
LIFE TECHNOLOGIES INC176 citations99
US5047342ASep 10, 1991
Cloning and expression of T5 DNA polymerase
LIFE TECHNOLOGIES INC188 citations99
US5948614ASep 7, 1999
Cloned DNA polymerases from thermotoga maritima and mutants thereof
LIFE TECHNOLOGIES INC116 citations98
US5912155AJun 15, 1999
Cloned DNA polymerases from Thermotoga neapolitana
LIFE TECHNOLOGIES INC117 citations98
US5939301AAug 17, 1999
Cloned DNA polymerases from Thermotoga neapolitana and mutants thereof
LIFE TECHNOLOGIES INC92 citations97
US5716819AFeb 10, 1998
Cloning and expression of T5 DNA polymerase reduced in 3'-to-5' exonuclease activity
LIFE TECHNOLOGIES INC40 citations96
US6015668AJan 18, 2000
Cloned DNA polymerases from thermotoga and mutants thereof
LIFE TECHNOLOGIES INC70 citations94
US5248605ASep 28, 1993
Cloning and expressing restriction endonucleases from haemophilus
LIFE TECHNOLOGIES INC22 citations93
US5334526AAug 2, 1994
Cloning and expression of AluI restriction endonuclease
LIFE TECHNOLOGIES INC27 citations92
US5312746AMay 17, 1994
Cloning and expressing restriction endonucleases and modification methylases from caryophanon
LIFE TECHNOLOGIES INC22 citations92
US5192675AMar 9, 1993
Cloned KpnI restriction-modification system
LIFE TECHNOLOGIES INC27 citations90
US5082784AJan 21, 1992
Cloned kpni restriction-modification system
LIFE TECHNOLOGIES INC32 citations90
US5541099AJul 30, 1996
Cloning and expression of T5 DNA polymerase reduced in 3'-to-5' exonuclease activity
LIFE TECHNOLOGIES INC17 citations82
US5304480AApr 19, 1994
Cloning and expressing XhoII restriction endonuclease and M.XhoII modification methylase from xanthomonas
LIFE TECHNOLOGIES INC15 citations82
US5231021AJul 27, 1993
Cloning and expressing restriction endonucleases and modification methylases from xanthomonas
LIFE TECHNOLOGIES INC19 citations82
US5147800ASep 15, 1992
Host expressing ngoaiii restriction endonuclease and modification methylase from neisseria
LIFE TECHNOLOGIES INC20 citations80
US5965399AOct 12, 1999
Cloning and expression of rat liver and porcine liver ribonuclease inhibitor
LIFE TECHNOLOGIES INC6 citations72
US5932440AAug 3, 1999
Mammalian ribonuclease inhibitors and use thereof
LIFE TECHNOLOGIES INC9 citations72
INVITROGEN CORP
11 patentsUS6830902B1Dec 14, 2004
Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis
INVITROGEN CORP42 citations95
US6506560B1Jan 14, 2003
Cloned DNA polymerases from Thermotoga and mutants thereof
INVITROGEN CORP64 citations94
US6989259B2Jan 24, 2006
Recombinant methods for making reverse transcriptases and mutants thereof
INVITROGEN CORP14 citations92
US6835561B1Dec 28, 2004
Composition of reverse transcriptases and mutants thereof
INVITROGEN CORP22 citations92
US6518019B2Feb 11, 2003
Compositions and methods for reverse transcription of nucleic acid molecules
INVITROGEN CORP26 citations92
US6444424B1Sep 3, 2002
Cloned DNA polymerases from Thermotoga neapolitana
INVITROGEN CORP34 citations92
US7265206B2Sep 4, 2007
Methods of production of proteins
INVITROGEN CORP10 citations90
US7223566B2May 29, 2007
Methods for production of proteins
INVITROGEN CORP10 citations90
US6306588B1Oct 23, 2001
Polymerases for analyzing or typing polymorphic nucleic acid fragments and uses thereof
INVITROGEN CORP30 citations90
US7259242B2Aug 21, 2007
Methods for production of proteins
INVITROGEN CORP9 citations79
US7115406B2Oct 3, 2006
Recombinant method for making RSV reverse transcriptases and mutants thereof
INVITROGEN CORP4 citations74
LIFE TECHNOLOGIES CORP
4 patentsUS7501237B2Mar 10, 2009
Polymerases for analyzing or typing polymorphic nucleic acid fragments and uses thereof
LIFE TECHNOLOGIES CORP62 citations95
US8043816B2Oct 25, 2011
Compositions and methods for temperature-dependent nucleic acid synthesis
LIFE TECHNOLOGIES CORP7 citations83
US8012715B2Sep 6, 2011
Methods for production of proteins
LIFE TECHNOLOGIES CORP1 citations60
US7736874B2Jun 15, 2010
Methods for cloning amplified nucleic acid molecules
LIFE TECHNOLOGIES CORP0 citations51
(unassigned)
2 patentsUS HEALTH
2 patentsTHE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES
2 patentsUS11718861B2Aug 8, 2023
Cancer immunotherapy by delivering class II MHC antigens using a VLP-replicon
THE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES2 citations70
US12049639B2Jul 30, 2024
Cancer immunotherapy by delivering class II MHC antigens using a VLP-replicon
THE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES0 citations59